Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Insulet Corp (PODD)

Insulet Corp (PODD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,039,374
  • Shares Outstanding, K 69,404
  • Annual Sales, $ 1,099 M
  • Annual Income, $ 16,800 K
  • 60-Month Beta 0.77
  • Price/Sales 15.48
  • Price/Cash Flow 227.79
  • Price/Book 40.27
Trade PODD with:

Options Overview Details

View History
  • Implied Volatility 50.61% ( +1.47%)
  • Historical Volatility 41.38%
  • IV Percentile 55%
  • IV Rank 49.79%
  • IV High 73.23% on 05/18/22
  • IV Low 28.17% on 11/23/21
  • Put/Call Vol Ratio 1.54
  • Today's Volume 33
  • Volume Avg (30-Day) 123
  • Put/Call OI Ratio 1.71
  • Today's Open Interest 5,532
  • Open Int (30-Day) 5,523

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.17
  • Number of Estimates 10
  • High Estimate 0.22
  • Low Estimate 0.07
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
226.05 +4.97%
on 10/03/22
274.09 -13.43%
on 09/09/22
-25.55 (-9.72%)
since 09/07/22
3-Month
216.95 +9.38%
on 07/13/22
283.28 -16.23%
on 08/25/22
+2.18 (+0.93%)
since 07/07/22
52-Week
181.00 +31.10%
on 05/12/22
324.81 -26.94%
on 11/10/21
-55.71 (-19.01%)
since 10/07/21

Most Recent Stories

More News
New Strong Sell Stocks for October 7th

GIII, PODD and LU have been added to the Zacks Rank #5 (Strong Sell) List on October 7, 2022.

GIII : 15.88 (-2.76%)
PODD : 237.29 (-3.35%)
LU : 2.24 (-5.88%)
Cutting Edge Medical Devices Offer Innovative Options for Diabetics

/PRNewswire/ -- In the modern technologically-driven healthcare landscape, the business model of medical device companies has evolved from device makers to...

ABT : 101.79 (-0.64%)
NMRD : 2.61 (+13.48%)
DXCM : 102.14 (+7.28%)
TNDM : 52.13 (-2.54%)
PODD : 237.29 (-3.35%)
Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial...

PODD : 237.29 (-3.35%)
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it has received CE marking under...

PODD : 237.29 (-3.35%)
3 Reasons to Hold Insulet (PODD) Stock in Your Portfolio

Investors continue to be optimistic about Insulet (PODD) on Omnipod's continued market access expansion.

MCK : 346.68 (-1.20%)
AMN : 111.25 (-0.37%)
PODD : 237.29 (-3.35%)
SWAV : 263.99 (-5.44%)
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received clearance from...

PODD : 237.29 (-3.35%)
Insulet (PODD) Q2 Earnings Miss Estimates, '22 Sales View Up

Insulet (PODD) posts better-than-expected revenues in Q2 with robust contributions from Total Omnipod.

MRK : 87.60 (+0.18%)
DGX : 123.31 (-2.18%)
MOH : 348.76 (-1.50%)
PODD : 237.29 (-3.35%)
Insulet to Present at Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at four upcoming...

PODD : 237.29 (-3.35%)
Insulet (PODD) Reports Q2 Loss, Tops Revenue Estimates

Insulet (PODD) delivered earnings and revenue surprises of -128.57% and 2.84%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PODD : 237.29 (-3.35%)
HAE : 75.94 (-1.24%)
Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three...

PODD : 237.29 (-3.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 251.27
2nd Resistance Point 248.20
1st Resistance Point 242.75
Last Price 237.29
1st Support Level 234.23
2nd Support Level 231.16
3rd Support Level 225.71

See More

52-Week High 324.81
Fibonacci 61.8% 269.87
Fibonacci 50% 252.90
Last Price 237.29
Fibonacci 38.2% 235.94
52-Week Low 181.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar